 |
|
Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease
Hyun Gyung Lee, Eun Mi Yang, Chan Jong Kim
Ann Pediatr Endocrinol Metab. 2021;26(3):199-204. Published online 2021 Sep 30 DOI: https://doi.org/10.6065/apem.2142046.023
|
|
Citations to this article as recorded by
 The Major Characteristics and Trends of Gifted Education Doctoral Dissertation Research From 2006 Through 2016
Hyeseong Lee, Marcia Gentry
Journal for the Education of the Gifted.2023; 46(4): 340. CrossRef Different doses of methimazole treatment of children and adolescents with graves’ disease: a clinical study based on 161 cases of outpatients
Peng Li, Wei Wang, Meiqin Yan, Xianhui Zhang, Jie Pan, Lina Gong
BMC Endocrine Disorders.2023;[Epub] CrossRef Updates in the Management of Graves Disease in Children
Yun Jeong Lee
The Ewha Medical Journal.2023;[Epub] CrossRef Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse”
Ji Hyun Kim
Annals of Pediatric Endocrinology & Metabolism.2022; 27(4): 245. CrossRef
|